InMed Pharmaceuticals Inc. (INM) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
InMed Pharmaceuticals Inc. (INM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.0M, listed on NASDAQ, employing roughly 13 people, carrying a beta of 0.57 to the broader market. InMed Pharmaceuticals Inc. Led by Eric A. Adams Chem., public since 2014-05-05.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for INM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.